Back to Search
ANTHONY CERVANTES, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1437918851Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Continuing medical education (CME) or continuing professional development (CPD): a need, a challenge, but also a must.
PMID 19380293·Clin Transl Oncol·2009
8-other
Melanin-concentrating hormone induces neurite outgrowth in human neuroblastoma SH-SY5Y cells through p53 and MAPKinase signaling pathways.
PMID 19540893·Peptides·2009
8-other
AMPSO: a new particle swarm method for nearest neighborhood classification.
PMID 19336325·IEEE Trans Syst Man Cybern B Cybern·2009
8-other
Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team.
PMID 19479978·Cancer·2009
3-trial
Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
PMID 19540072·Int J Radiat Oncol Biol Phys·2009
3-trial
Prognostic heterogeneity of endosonographic T3 rectal cancer.
PMID 19404075·Dis Colon Rectum·2009
8-other
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.
PMID 19153116·Ann Oncol·2009
3-trial
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
PMID 19465426·Ann Oncol·2009
4-observational
[Pancreatic and periampullary tumors: morbidity, mortality, functional results and long-term survival].
PMID 19616203·Cir Esp·2009
8-other
Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer.
PMID 18790964·Ann Oncol·2008
6-review
Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?
PMID 18305055·Oncologist·2008
6-review
The treatment of advanced gastric cancer: current strategies and future perspectives.
PMID 18611865·Ann Oncol·2008
6-review
Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.
PMID 18665167·Br J Cancer·2008
3-trial
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
PMID 17963264·Cancer·2007
4-observational
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women.
PMID 17522430·Cancer Biomark·2007
8-other
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
PMID 17664470·J Clin Oncol·2007
4-observational
Phosphorylation of the atypical kinesin Costal2 by the kinase Fused induces the partial disassembly of the Smoothened-Fused-Costal2-Cubitus interruptus complex in Hedgehog signalling.
PMID 17881487·Development·2007
7-preclinical
[Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases].
PMID 17916288·Cir Esp·2007
8-other
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
PMID 18024868·J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1431 SW 1ST AVE # BITZER7
OCALA, FL 34471 - Phone
- (352) 401-8311
Quick Facts
- NPI
- 1437918851
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile